Vanguard Group Inc Ardelyx, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARDX
# of Institutions
222Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$114 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$98 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$75.9 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$74.6 Million0.06% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$73.2 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $1.01B
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...